Literature DB >> 26003426

The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review.

T Hasenoehrl1, M Keilani, T Sedghi Komanadj, M Mickel, M Margreiter, M Marhold, R Crevenna.   

Abstract

PURPOSE: Physical exercise has been shown to be an effective, safe, and quite inexpensive method to reduce cardiovascular and metabolic risk factors and is currently in the process of establishing its relevance for cancer specific morbidity and mortality. The aim of this systematic review was to focus on specific effects of resistance exercise (RE) in the adjuvant therapy and rehabilitation of prostate cancer patients (PCaPs) receiving or having received androgen deprivation therapy (ADT).
METHODS: A systematic literature search focusing on relevant and peer-reviewed studies published between 1966 and September 2014, using PubMed, EMBASE, MEDLINE, SCOPUS, and Cochrane Library databases, was conducted.
RESULTS: The majority of studies demonstrated RE as an effective and safe intervention to improve muscular strength and performance, fatigue and quality of life (QoL) in PCaPs, while there is inconclusive evidence concerning cardiovascular performance, body composition, blood lipids, bone mineral density (BMD), and immune response.
CONCLUSION: Existing evidence leads to the conclusion that RE seems to be a safe intervention in PCaPs with beneficial effects on physical performance capacity and QoL. Nevertheless, further research in this field is urgently needed to increase understanding of exercise interventions in PCaPs.

Entities:  

Mesh:

Year:  2015        PMID: 26003426     DOI: 10.1007/s00520-015-2782-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  62 in total

1.  Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomized controlled study.

Authors:  Sung-Woo Park; Tae Nam Kim; Jong-Kil Nam; Hong Koo Ha; Dong Gil Shin; Wan Lee; Mi-Sook Kim; Moon Kee Chung
Journal:  Urology       Date:  2012-06-29       Impact factor: 2.649

2.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

3.  A randomized trial of aerobic versus resistance exercise in prostate cancer survivors.

Authors:  Daniel Santa Mina; M H Alibhai S; Andrew G Matthew; Crissa L Guglietti; Meysam Pirbaglou; John Trachtenberg; Paul Ritvo
Journal:  J Aging Phys Act       Date:  2012-12-10       Impact factor: 1.961

4.  Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.

Authors:  Angela S Alberga; Roanne J Segal; Robert D Reid; Chris G Scott; Ronald J Sigal; Farah Khandwala; James Jaffey; George A Wells; Glen P Kenny
Journal:  Support Care Cancer       Date:  2011-05-03       Impact factor: 3.603

Review 5.  Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

6.  Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.

Authors:  Prue Cormie; Daniel A Galvão; Nigel Spry; David Joseph; Raphael Chee; Dennis R Taaffe; Suzanne K Chambers; Robert U Newton
Journal:  BJU Int       Date:  2014-07-27       Impact factor: 5.588

7.  Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices.

Authors:  Jean K Brown; Tim Byers; Colleen Doyle; Kerry S Coumeya; Wendy Demark-Wahnefried; Lawrence H Kushi; Anne McTieman; Cheryl L Rock; Noreen Aziz; Abby S Bloch; Barbara Eldridge; Kathryn Hamilton; Carolyn Katzin; Amy Koonce; Julie Main; Connie Mobley; Marion E Morra; Margaret S Pierce; Kimberly Andrews Sawyer
Journal:  CA Cancer J Clin       Date:  2003 Sep-Oct       Impact factor: 508.702

8.  Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia.

Authors:  Frances Dockery; Christopher J Bulpitt; Sanjiv Agarwal; Mandy Donaldson; Chakravarthi Rajkumar
Journal:  Clin Sci (Lond)       Date:  2003-02       Impact factor: 6.124

9.  Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases.

Authors:  P Cormie; R U Newton; N Spry; D Joseph; D R Taaffe; D A Galvão
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-08-06       Impact factor: 5.554

10.  Relationship between low free testosterone levels and loss of muscle mass.

Authors:  Atsumu Yuki; Rei Otsuka; Rumi Kozakai; Itsuko Kitamura; Tomohiro Okura; Fujiko Ando; Hiroshi Shimokata
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  22 in total

Review 1.  Cancer rehabilitation in Austria--aspects of Physical Medicine and Rehabilitation.

Authors:  Bruno Maehr; Mohammad Keilani; Christoph Wiltschke; Marco Hassler; Thomas Licht; Christine Marosi; Elisabeth Huetterer; Fadime Cenik; Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2016-01-12

Review 2.  Resistance exercise and secondary lymphedema in breast cancer survivors-a systematic review.

Authors:  M Keilani; T Hasenoehrl; M Neubauer; R Crevenna
Journal:  Support Care Cancer       Date:  2015-12-30       Impact factor: 3.603

Review 3.  Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis.

Authors:  Camila S Padilha; Poliana Camila Marinello; Daniel A Galvão; Robert U Newton; Fernando H Borges; Fernando Frajacomo; Rafael Deminice
Journal:  J Cancer Surviv       Date:  2017-01-04       Impact factor: 4.442

4.  Nested Cohort Study to Identify Characteristics That Predict Near-Term Disablement From Lung Cancer Brain Metastases.

Authors:  Andrea L Cheville; Jeffrey R Basford; Ian Parney; Ping Yang; Felix E Diehn
Journal:  Arch Phys Med Rehabil       Date:  2016-09-22       Impact factor: 3.966

5.  A systematic review of physical activity-based behaviour change interventions reaching men with prostate cancer.

Authors:  A Finlay; G Wittert; C E Short
Journal:  J Cancer Surviv       Date:  2018-05-16       Impact factor: 4.442

6.  "Kicked out into the real world": prostate cancer patients' experiences with transitioning from hospital-based supervised exercise to unsupervised exercise in the community.

Authors:  Mette L K Schmidt; Peter Østergren; Prue Cormie; Anne-Mette Ragle; Jens Sønksen; Julie Midtgaard
Journal:  Support Care Cancer       Date:  2018-06-21       Impact factor: 3.603

Review 7.  Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy.

Authors:  Mark A Moyad; Robert U Newton; Ulf W Tunn; Damian Gruca
Journal:  Res Rep Urol       Date:  2016-08-16

8.  Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol.

Authors:  Peter Østergren; Anne-Mette Ragle; Henrik Jakobsen; Tobias Wirenfeldt Klausen; Anders Vinther; Jens Sønksen
Journal:  BMJ Open       Date:  2016-06-29       Impact factor: 2.692

Review 9.  Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators.

Authors:  Fadime Cenik; Dieter Schoberwalter; Mohammad Keilani; Bruno Maehr; Michael Wolzt; Maximilian Marhold; Richard Crevenna
Journal:  Wien Klin Wochenschr       Date:  2016-07-25       Impact factor: 1.704

10.  Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study.

Authors:  Cadeyrn J Gaskin; Steve F Fraser; Patrick J Owen; Melinda Craike; Liliana Orellana; Patricia M Livingston
Journal:  J Cancer Surviv       Date:  2016-04-20       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.